R&D staff designation
How R&D staff are identified, and how pay for part-time R&D staff is split between R&D and production.
Solutions · IPO R&D compliance
The basis for collecting R&D investment, the split between capitalized and expensed costs, and differences from the tax basis are all points of attention in listing review. Jouyun R&D Manager keeps complete business records, reports R&D investment data on the IPO basis and explains the differences from other bases.
Review focus areas
How R&D staff are identified, and how pay for part-time R&D staff is split between R&D and production.
Whether the method and basis for allocating shared equipment, premises, utilities and other resources are reasonable and consistent.
When and under what conditions R&D spending is capitalized, and whether capitalized amounts trace back to specific projects.
When R&D investment in the financial statements differs from the super deduction and HNTE filing bases, the differences need to be explained item by item.
Approach
Staff, hours, expenses and vouchers are managed in one system, and every basis is calculated from the same source data.
Five bases (accounting, super deduction, HNTE, IPO and as-filed) are calculated in parallel.
Basis variance analysis explains the source and cause of each amount difference, item by item.
Initiation, changes, hours and approvals are all recorded, and historical records keep their versions.
Key capabilities
R&D investment as a share of operating revenue, and capitalization details.
Item-by-item comparison with the accounting, super deduction and HNTE bases.
R&D staff designation and project allocation ratios, with pay allocated according to hours.
Staff and equipment costs allocated by work hours and machine hours, with the basis retained.
Approvals for initiation, changes, time entries and vouchers are fully recorded.
R&D investment across group companies and entities, viewed in one place.
Reference standards
The final disclosure basis depends on the judgment of the company and its intermediaries.
ASBE No. 6
《Accounting Standard for Business Enterprises No. 6: Intangible Assets》
Treatment of research and development phase spending, and capitalization criteria
Regulatory Rules Guidelines
《Guidelines for the Application of Regulatory Rules (Issuance) No. 9: R&D Personnel and R&D Investment》
Review requirements for R&D staff designation and R&D investment collection
Caishui [2015] No. 119
《Notice on Improving the Policy of Pre-tax Super Deduction of R&D Expenses》
Scope of R&D expenses on the tax basis
White paper · 118 pages
Drawing on 68 terminated Shanghai and Shenzhen IPO filings, 12 sets of formal regulatory documents and listed-company annual reports, this paper maps what reviewers look at in R&D activity recognition, cost allocation, accounting, tax incentives and disclosure. It includes ten working-paper templates and a full project reconciliation example.
R&D Manager produces R&D investment data and details on the IPO basis as a basis for preparing filing materials. The final disclosure basis is determined jointly by the company, its sponsor and its accounting firm.
Past years can be imported from voucher, balance and hours data and recalculated on a consistent basis, with import records kept.
The Flagship edition is designed for pre-IPO companies, R&D compliance reviews at listed companies, and large groups. The pricing page lists the target companies and included capabilities of both editions.
A product consultant will explain how to use the Flagship edition in line with the company’s listing plan.